INOZYME

Welcome to the Brand page for “INOZYME”, which is offered here for Therapeutic pharmaceutical for the diagnosis and treatment of diseases or disorders afflicting the bone, kidney and tissue, diseases of abnormal mineralization and calcification, diseases of the circulatory system, diseases caused by inborn errors of metabolism, and diseases caused by abnormal intimal proliferation; pharmaceutical products for use in the diagnosis and treatment of bone, kidney and tissue diseases, diseases of abnormal mineralization and calcification, diseases of the circulatory system, diseases caused by inborn errors of metabolism, and diseases caused by abnormal intimal proliferation;.

Its status is currently believed to be active. Its class is unavailable. “INOZYME” is believed to be currently owned by “Inozyme Pharma, Inc.”